Mail & Guardian (Johannesburg) - March 06, 1998
Angella Johnson
Documents used to attack the ANC this week for its alleged involvement in the company said that Joshua Nxomalo would receive 1% for introducing its directors to the party.
Nxomalo, a former non-ranking Umkhonto weSizwe cadre, says although he knows Deputy President Thabo Mbeki and other ANC members, he did not arrange for them to contact the Virodene founders.
"I may have introduced the shareholders to prominent people who then introduced them to the government. But in any case, I don't see where the ANC has done anything for the company," he insists.
Mbeki last December brokered peace when warring factions within Cyropreservation Technologies threatened the project.
Nxomalo claims Ziggy Visser wrote the document stating that the ANC would receive 6% under pressure from other partners baying for a complete disclosure of the company's affairs late last year.
"It was done in haste and was merely an interim working paper. Ziggy told me he had said this in a state of confusion and had really meant to say Reconstruction and Development Programme, or some other kind of black empowerment."
Nxomalo, who runs a Johannesburg-based construction company, says he became interested in finding a cure for HIV and Aids after seeing several of his former ANC comrades die from the virus they had contracted in exile.
"This thing is killing black people in droves, and we want to ensure a cure gets to them quickly and cheaply. The Vissers wanted to bring in black businessmen who might want to invest in Virodene."
Nxomalo says that thus far none of the potential black investors has taken the bait. "They did not trust the way the company was structured."
Neither, it seems, did shareholder Carl Landauer, a cardiothoracic surgeon at Pretoria University, who went to court to try to have Ziggy Visser removed as manager of the company.
Landauer accuses the Vissers of running the company as if it were their own personal fiefdom, and claims other political groups had also been earmarked for free shares.
"We became suspicious that the corporation had been involved in irregular and irresponsible dealing. We wanted to make sure no kickbacks were offered. That's why we went to court last November - and thank God, or we might not have uncovered this," he said.
980306
MG980302
Copyright © 1998 - Daily Mail & Guardian. For information about the content or for permission to redistribute, publish or use for broadcast, contact the publisher.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 1998. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1998. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .